Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells

Molecular and Cellular Endocrinology

Volumn 369, Issue 1-2, 2013, Pages 130-139

  Kim, Si Hyoung ^a   Kang, Jun Goo ^a   Kim, Chul Sik ^a   Ihm, Sung Hee ^a   Choi, Moon Gi ^a   Yoo, Hyung Joon ^a   Lee, Seong Jin ^a  

^a Hallym University   (South Korea)

Author keywords

Anaplastic thyroid carcinoma; Apigenin; Apoptosis; C Myc; P38; P53

Indexed keywords

APIGENIN; MYC PROTEIN; PROTEIN P53; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; THYROID CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APIGENIN; APOPTOSIS; CELL LINE, TUMOR; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MYC; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875054444     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.01.012     Document Type: Article

References (38)

1. Akaishi J., Sugino K., Kitagawa W., Nagahama M., Kameyama K., Shimizu K., Ito K., Ito K. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid 2011, 21:1183-1189.
2. Asakawa H., Kobayashi T., Komoike Y., Yanagawa T., Takahashi M., Wakasugi E., Maruyama H., Tamaki Y., Matsuzawa Y., Monden M. Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis. J. Clin. Endocrinol. Metab. 1996, 81:3547-3552.
3. Chen W.Y., Hsieh Y.A., Tsai C.I., Kang Y.F., Chang F.R., Wu Y.C., Wu C.C. Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase π. Invest. New Drugs 2011, 29:1347-1359.
4. Choi A.Y., Choi J.H., Lee J.Y., Yoon K.S., Choe W., Ha J., Yeo E.J., Kang I. Apigenin protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis. Neurochem. Int. 2010, 57:143-152.
5. Conzen S.D., Gottlob K., Kandel E.S., Khanduri P., Wagner A.J., O'Leary M., Hay N. Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol. Cell Biol. 2000, 20:6008-6018.
6. Desbiens K.M., Deschesnes R.G., Labrie M.M., Desfosses Y., Lambert H., Landry J., Bellmann K. C-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade. Biochem. J. 2003, 372:631-641.
7. Deschesnes R.G., Huot J., Valerie K., Landry J. Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol. Biol. Cell 2001, 12:1569-1582.
8. Geahlen R.L., Koonchanok N.M., McLaughlin J.L., Pratt D.E. Inhibition of protein-tyrosine kinase activity by flavonoids and related compounds. J. Nat. Prod. 1989, 52:982-986.
9. Gong X., Liu A., Ming X., Deng P., Jiang Y. UV-induced interaction between p38 MAPK and p53 serves as a molecular switch in determining cell fate. FEBS Lett. 2010, 584:4711-4716.
10. Gupta S., Afaq F., Mukhtar H. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 2002, 21:3727-3738.
11. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
12. Hoffman B., Liebermann D.A. Apoptotic signaling by c-MYC. Oncogene 2008, 27:6462-6472.
13. Hueber A.O., Zörnig M., Lyon D., Suda T., Nagata S., Evan G.I. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 1997, 278:1305-1309.
14. Juin P., Hueber A.O., Littlewood T., Evan G. C-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 1999, 13:1367-1381.
15. Juin P., Hunt A., Littlewood T., Griffiths B., Swigart L.B., Korsmeyer S., Evan G. C-Myc functionally cooperates with Bax to induce apoptosis. Mol. Cell Biol. 2002, 22:6158-6169.
16. Kalra N., Kumar V. C-Fos is a mediator of the c-Myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 2004, 279:25313-25319.
17. Kondo T., Ezzat S., Asa S.L. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat. Rev. Cancer 2006, 6:292-306.
18. Kurihara T., Ikeda S., Ishizaki Y., Fujimori M., Tokumoto N., Hirata Y., Ozaki S., Okajima M., Sugino K., Asahara T. Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers. Thyroid 2004, 14:1020-1029.
19. Nikiforov Y.E., Nikiforova M.N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 2011, 7:569-580.
20. Patel D., Shukla S., Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise. Int. J. Oncol. 2007, 30:233-245.
21. - symporter-transfected follicular thyroid carcinoma cell line. Eur. J. Endocrinol. 2004, 150:557-564.
22. Schweppe R.E., Klopper J.P., Korch C., Pugazhenthi U., Benezra M., Knauf J.A., Fagin J.A., Marlow L.A., Copland J.A., Smallridge R.C., Haugen B.R. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J. Clin. Endocrinol. Metab. 2008, 93:4331-4341.
23. Shukla S., Gupta S. Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells. Mol. Carcinog. 2004, 39:114-126.
24. Shukla S., Gupta S. Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radic. Biol. Med. 2008, 44:1833-1845.
25. Shukla S., Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm. Res. 2010, 27:962-978.
26. Shukla S., MacLennan G.T., Flask C.A., Fu P., Mishra A., Resnick M.I., Gupta S. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res. 2007, 67:6925-6935.
27. Smallridge R.C., Copland J.A. Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin. Oncol. 2010, 22:486-497.
28. Smallridge R.C., Marlow L.A., Copland J.A. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr. Relat. Cancer 2009, 16:17-44.
29. Takagaki N., Sowa Y., Oki T., Nakanishi R., Yogosawa S., Sakai T. Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway. Int. J. Oncol. 2005, 26:185-189.
30. Vargo M.A., Voss O.H., Poustka F., Cardounel A.J., Grotewold E., Doseff A.I. Apigenin-induced-apoptosis is mediated by the activation of PKCδ and caspases in leukemia cells. Biochem. Pharmacol. 2006, 72:681-692.
31. Vermeulen K., Berneman Z.N., van Bockstaele D.R. Cell cycle and apoptosis. Cell Prolif. 2003, 36:165-175.
32. Wang I.K., Lin-Shiau S.Y., Lin J.K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer 1999, 35:1517-1525.
33. Way T.D., Kao M.C., Lin J.K. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 2004, 279:4479-4489.
34. Yin F., Giuliano A.E., van Herle A.J. Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid 1999, 9:369-376.
35. Yin F., Giuliano A.E., van Herle A.J. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells. Anticancer Res. 1999, 19:4297-4304.
36. Zheng P.W., Chiang L.C., Lin C.C. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci. 2005, 76:1367-1379.
37. Zhong Y., Krisanapun C., Lee S.H., Nualsanit T., Sams C., Peungvicha P., Baek S.J. Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53. Eur. J. Cancer 2010, 46:3365-3374.
38. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 1998, 12:2424-2433.